URCC21038 DiRECT Coordinator Training

We are pleased to offer another training opportunity for URCC21038 DiRECT. This will be held on April 16, 2024, from 3:00pm – 4:30pm (EST) eastern time. 

Please remember to use your first and last name when signing into Zoom to attend the training.

**Special Note** 

We will be covering the newly activated Amendment 1 during this training! Please join for the new amendment information even if you already have a training certificate for DiRECT!

The primary purpose of the study is to compare immune related adverse events (irAE) between AA and EA patients with first year of starting immune checkpoint inhibitors (ICI’s). 

Please complete the Training Contact Information document and send it back to urcc_21038@urmc.rochester.edu. Once we receive a copy of this, we will send you the zoom link for the training.